Glipizide CAS 29094-61-9

Product Description:

Product Name: Glipizide CAS NO: 29094-61-9

Synonyms:

N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide;

Glipizide Solution, 100ppm;

n-(4-(beta-(5-methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-n’-cycloh;

Chemical & Physical Properties:

Appearance: White or off-white crystalline powder

Assay :≥99.0%

Density: 1.34 g/cm3

Melting Point: 208-209℃

Refractive Index: 1.597

Storage Condition: Store in a tightly closed container. Store in a dry area. Store at around 20℃

Vapour Pressure: 0.0±2.2 mmHg at 25℃

Safety Information:

RTECS: YS7640000

Safety Statements: S24/25

HS Code: 2935009090

WGK Germany: 3

Risk Statement: R21

Hazard Codes: Xi; Xn

Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.

Originally available in 1984, it is marketed by Pfizer under the brand name Glucotrol in the USA, where Pfizer sells Glucotrol in doses of 5 and 10 milligrams and Glucotrol XL (an extended release form of glipizide) in doses of 2.5, 5, and 10 milligrams. Other companies also market glipizide, most commonly extended release tablets of 5 and 10 milligrams.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.